DANA MELLO: Open Payments
NPI 1568943629 · PLANT CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,563 in 130 payments from 21 companies in 2025. Trend: 2023 $1,451 · 2024 $2,600 · 2025 $4,563
Food & beverage: $3,105Consulting: $1,350Education: $109
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $1,778 |
| Endologix LLC | 15 | $397 |
| GENZYME CORPORATION | 13 | $389 |
| QOL Medical, LLC | 11 | $363 |
| ABBVIE INC. | 19 | $345 |
| Madrigal Pharmaceuticals | 14 | $295 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $156 |
| PFIZER INC. | 7 | $154 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $143 |
| Lilly USA, LLC | 4 | $96 |
Products named: TREMFYA, DUPIXENT, Sucraid, REZDIFFRA, Alto Abdominal Stent Graft System, AFX2 Bifurcated Endograft System, XIFAXAN, RINVOQ.
Industry payments across FL — which companies pay providers there.
